Spyre Therapeutics (SYRE) Treasury Shares (2015 - 2024)

Spyre Therapeutics (SYRE) has 8 years of Treasury Shares data on file, last reported at $76932.0 in Q4 2025.

• Quarterly Treasury Shares fell 33.33% year-over-year to $76932.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $76932.0 (down 33.33% YoY) and the FY2025 annual result came in at $76932.0, down 33.33% from the prior year.
• Treasury Shares fell to $76932.0 in Q4 2025, from $115398.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.1 million in Q3 2023 to a low of $76932.0 in Q4 2025.
• A 4-year average of $326981.1 and a median of $181500.0 in 2022 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares jumped 624.0% — and 2025, when it sank 33.33%.
• Tracing SYRE's Treasury Shares over 4 years: stood at $150000.0 in 2022, then changed by 0.0% to $150000.0 in 2023, then fell by 23.07% to $115398.0 in 2024, then plunged by 33.33% to $76932.0 in 2025.
• The last three Treasury Shares figures came in at $76932.0 (Q4 2025), $115398.0 (Q4 2024), and $272000.0 (Q1 2024), per Business Quant data.